Topic: spinal cord stimulation
A new trial published in Nature has seen a combination of spinal cord therapy (SCS) and physical therapy help patients walk again.
Two of four paralyzed patients who underwent an experimental electrode treatment and physical therapy regained the ability to walk with limited help.
Backed by some big names, media-quiet Australian med dev company Saluda Medical is looking to use its closed-loop neuromodulation technology to monitor signals traveling along the spine while also stimulating the body itself.
Nevro got a CE mark for a new version of its SCS therapy for chronic pain.
Mebias presented rat data showing its mu opioid drugs could become a weapon in the scramble to combat the opioid epidemic.
The FDA cleared Medtronic's latest spinal cord stimulation system for the treatment of chronic intractable pain.
Stimwave scored FDA clearance for its tiny, injectable, MRI-safe neurostimulator for chronic peripheral nerve pain.
Saluda Medical has raised $40 million in a round led by a GSK's bioelectronic medicine VC fund.
Nevro is filing a patent infringement suit against Boston Scientific, which had its own patent suit against Nevro dismissed almost a year ago.
Just one week after bagging a CE mark for its MRI-compatible CRT pacemaker, St. Jude Medical announced an FDA full-body MRI label for its recharge-free spinal cord stimulation system.